Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Bechara

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Cancer Research and Clinical Oncology|September 15, 2016
Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinomaT Gambichler, S Mohtezebsade, U Wieland, et al.
Experimental Dermatology|April 11, 2008
What causes hidradenitis suppurativa?H Kurzen, I Kurokawa, G B E Jemec, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2018
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working groupC C Zouboulis, F G Bechara, J L Dickinson-Blok, et al.
The British Journal of Dermatology|June 22, 2017
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severityC C Zouboulis, T Tzellos, A Kyrgidis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2020
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019)A J P Clover, F de Terlizzi, G Bertino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 19, 2024
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: TreatmentC C Zouboulis, F G Bechara, F Benhadou, et al.
The British Journal of Dermatology|October 29, 2017
Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and IIL Thorlacius, A Garg, J R Ingram, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Cancer Research and Clinical Oncology|September 15, 2016
Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinomaT Gambichler, S Mohtezebsade, U Wieland, et al.
Experimental Dermatology|April 11, 2008
What causes hidradenitis suppurativa?H Kurzen, I Kurokawa, G B E Jemec, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 4, 2018
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working groupC C Zouboulis, F G Bechara, J L Dickinson-Blok, et al.
The British Journal of Dermatology|June 22, 2017
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severityC C Zouboulis, T Tzellos, A Kyrgidis, et al.
European Journal of Cancer (Oxford, England : 1990)|August 25, 2020
Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019)A J P Clover, F de Terlizzi, G Bertino, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 19, 2024
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: TreatmentC C Zouboulis, F G Bechara, F Benhadou, et al.
The British Journal of Dermatology|October 29, 2017
Towards global consensus on core outcomes for hidradenitis suppurativa research: an update from the HISTORIC consensus meetings I and IIL Thorlacius, A Garg, J R Ingram, et al.
Pageof 6